Nicholas Investment Partners, LP - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 167 filers reported holding REPLIGEN CORP in Q3 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nicholas Investment Partners, LP ownership history of REPLIGEN CORP
ValueSharesWeighting
Q4 2022$14,812,424
-9.8%
87,487
-0.3%
1.30%
-14.7%
Q3 2022$16,414,000
-9.6%
87,722
-21.5%
1.52%
-11.3%
Q2 2022$18,153,000
-17.5%
111,779
-4.5%
1.72%
+9.6%
Q1 2022$22,004,000
-15.0%
116,987
+19.7%
1.57%
-4.4%
Q4 2021$25,889,000
+1.1%
97,752
+10.3%
1.64%
-12.4%
Q3 2021$25,611,000
-6.1%
88,621
-35.1%
1.87%
+9.3%
Q2 2021$27,278,000
-1.3%
136,652
-3.8%
1.71%
-11.2%
Q1 2021$27,626,000
+10.5%
142,103
+8.9%
1.93%
-0.3%
Q4 2020$25,006,000
+30.2%
130,491
+0.2%
1.93%
-7.0%
Q3 2020$19,210,000
+406.9%
130,201
+324.6%
2.08%
+170.1%
Q2 2020$3,790,000
-42.4%
30,661
-55.0%
0.77%
-40.0%
Q1 2020$6,576,000
-8.2%
68,122
-12.0%
1.28%
+73.6%
Q4 2019$7,164,000
-30.8%
77,450
-42.6%
0.74%
-15.2%
Q3 2019$10,346,000
+113.4%
134,904
+139.1%
0.87%
+95.5%
Q2 2019$4,849,000
+44.7%
56,420
-0.6%
0.44%
+48.8%
Q1 2019$3,352,000
-4.6%
56,742
-14.8%
0.30%
-20.9%
Q4 2018$3,514,000
-5.4%
66,631
-0.5%
0.38%
+26.8%
Q3 2018$3,714,000
-13.6%
66,967
-26.7%
0.30%
-1.3%
Q2 2018$4,297,000
+40.2%
91,353
+7.8%
0.30%
+37.9%
Q1 2018$3,066,000
-22.5%
84,754
-22.3%
0.22%
+67.2%
Q4 2017$3,956,000
+29.4%
109,048
+36.7%
0.13%
-37.9%
Q3 2017$3,057,000
-7.4%
79,773
+0.2%
0.21%
-9.4%
Q2 2017$3,300,000
+18.2%
79,650
+0.5%
0.23%
+18.3%
Q1 2017$2,792,000
-9.5%
79,291
-20.7%
0.20%
-15.8%
Q4 2016$3,084,000
-22.6%
99,992
-24.3%
0.23%
-11.7%
Q3 2016$3,985,000
+10.3%
132,0080.0%0.26%
+5.6%
Q2 2016$3,612,000
+49.3%
132,008
+46.3%
0.25%
+41.8%
Q1 2016$2,420,000
-28.9%
90,215
-25.0%
0.18%
-24.7%
Q4 2015$3,402,000
+75.5%
120,263
+72.7%
0.24%
+69.1%
Q3 2015$1,939,000
-26.7%
69,634
+8.7%
0.14%
-17.8%
Q2 2015$2,645,000
+3.0%
64,082
-24.3%
0.17%
+5.0%
Q1 2015$2,569,000
-37.9%
84,625
-59.5%
0.16%
-37.8%
Q4 2014$4,137,000
-0.4%
208,921
+0.2%
0.26%0.0%
Q3 2014$4,152,000
-7.2%
208,520
+6.2%
0.26%
-1.5%
Q2 2014$4,475,000
+69.1%
196,370
-4.6%
0.26%
+20.1%
Q1 2014$2,647,000
-24.0%
205,842
-19.4%
0.22%
-17.7%
Q4 2013$3,482,000
+19.4%
255,287
-2.9%
0.27%
+9.9%
Q3 2013$2,917,000
+39.6%
263,042
+3.8%
0.24%
+24.7%
Q2 2013$2,089,000253,5160.19%
Other shareholders
REPLIGEN CORP shareholders Q3 2014
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders